Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63234 1503498110HCLSReviewIndonesiaAugust2017.pdf
Energy Boardroom

Italy's move to fund unapproved use of Roche's Avastin alarms the industry

11.06.2014 / Fierce Pharma

In the U.S. pushing drugs for unapproved uses has gotten companies into big trouble. In Italy, the opposite is now true. To save money, the government will pay for patients to be treated for an eye disease with Roche's Avastin, a drug not approved for that use, and has taken legal action against the Swiss drugmaker and marketing partner Novartis for steering physicians toward the pricier Lucentis, which is.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: